ENTITY

Dynavax Technologies (DVAX US)

4
Analysis
Health CareUnited States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Company Event22 Feb 2025 05:00 • Upcoming
Add To Calendar
Company Event08 Nov 2024 05:30 • Latest
Company Event07 Aug 2024 04:30
Company Event09 May 2024 04:30
Company Event23 Feb 2024 05:30
x